Comprehensive Alcohol Research Centers (P60 Clinical Trial Optional) | RFA AA 20 002

Opportunity Information: Apply for RFA AA 20 002

The Comprehensive Alcohol Research Centers (P60 Clinical Trial Optional) funding opportunity (RFA-AA-20-002) is a National Institutes of Health grant run through the National Institute on Alcohol Abuse and Alcoholism (NIAAA). It is designed to support large, interdisciplinary alcohol research centers that bring together multiple investigators and complementary lines of work to address alcohol use disorder (AUD) and the broader impacts of alcohol on health and disease. The basic idea is to fund coordinated, collaborative research programs that can do more than isolated projects by creating a shared scientific vision, common resources, and cross-cutting methods that move the field forward.

NIAAA is looking for centers that provide leadership in alcohol-related research, including development of research methods and broad dissemination of findings and tools. The scientific scope is intentionally broad and can include studies on the nature and causes of AUD, including etiology and genetics, as well as improvements in diagnosis, treatment, and prevention. The opportunity also emphasizes research on alcohol-related end-organ diseases and other health consequences, and it recognizes that alcohol can have biomedical, psychosocial, and economic impacts across the entire lifespan. Where it is relevant and a significant public health concern, research on comorbid conditions can be included, reflecting the reality that AUD often overlaps with other disorders and health challenges.

A major expectation of the center model is innovation and infrastructure. Beyond producing findings, funded centers are meant to be drivers of new research methods, technologies, and approaches that enable sustained, goal-directed work. In practice, this typically means building shared cores, harmonized protocols, and collaborative structures that help multiple projects work together efficiently and produce results that are larger in impact than the sum of individual studies. The notice also indicates that clinical trials are optional, meaning applicants may propose clinical trial work if it fits their aims, but they are not required to include a clinical trial to be competitive.

Eligibility is broad and includes many types of U.S.-based organizations. Eligible applicants include state, county, city or township, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; other Native American tribal organizations; public housing authorities and Indian housing authorities; nonprofits with and without 501(c)(3) status (excluding institutions of higher education in those nonprofit categories as listed); for-profit organizations (other than small businesses); and small businesses. The opportunity also explicitly highlights additional eligible applicant types such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, regional organizations, eligible federal agencies, tribal governments that are not federally recognized, and U.S. territories or possessions.

Foreign eligibility is restricted in a specific way. Non-domestic (non-U.S.) entities and non-domestic (non-U.S.) institutions are not eligible to apply as the primary applicant organization, and non-domestic components of U.S. organizations are also not eligible to apply. However, foreign components are allowed when they meet the NIH definition in the NIH Grants Policy Statement, meaning a U.S. applicant may include certain foreign collaborations or activities as part of the overall project when well-justified and consistent with NIH policy.

From the source details provided, this is a discretionary grant in the health category (CFDA 93.273). The opportunity lists an award ceiling of $1,250,000, with an original closing date of 2019-11-14, and a creation date of 2019-07-11. Overall, the program is structured to support high-impact, collaborative center-based research that advances understanding of AUD and alcohol-related harms, while also building durable scientific capabilities and sharing knowledge and tools that can influence the field beyond the funded institution.

• The National Institutes of Health in the health sector is offering a public funding opportunity titled "Comprehensive Alcohol Research Centers (P60 Clinical Trial Optional)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.273.
• This funding opportunity was created on 2019-07-11.
• Applicants must submit their applications by 2019-11-14. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Each selected applicant is eligible to receive up to $1,250,000.00 in funding.
• Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.

Apply for RFA AA 20 002

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: